Amicus Therapeutics, Inc.
FOLD
$9.92
$0.141.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 263.84M | 231.00M | 250.57M | 249.95M | 249.76M |
| Total Receivables | 113.84M | 105.85M | 88.32M | 101.10M | 98.07M |
| Inventory | 177.93M | 154.88M | 132.41M | 118.78M | 115.34M |
| Prepaid Expenses | 38.46M | 46.29M | 39.49M | 34.91M | 35.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 594.07M | 538.01M | 510.80M | 504.74M | 498.47M |
|
|
|||||
| Total Current Assets | 594.07M | 538.01M | 510.80M | 504.74M | 498.47M |
| Net Property, Plant & Equipment | 49.31M | 50.56M | 50.86M | 51.66M | 53.58M |
| Long-term Investments | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Goodwill | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Total Other Intangibles | 14.74M | 15.57M | 16.39M | 17.20M | 18.03M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.90M | 13.37M | 14.00M | 13.64M | 18.68M |
| Total Assets | 868.81M | 815.30M | 789.84M | 785.03M | 786.56M |
|
|
|||||
| Total Accounts Payable | 19.10M | 13.89M | 14.45M | 12.95M | 13.48M |
| Total Accrued Expenses | 171.17M | 145.14M | 129.88M | 100.49M | 132.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.66M | 8.61M | 8.56M | 8.46M | 8.54M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 26.81M | 3.23M |
| Total Other Current Liabilities | -- | -- | -- | 26.81M | 3.23M |
| Total Current Liabilities | 198.93M | 167.65M | 152.89M | 148.70M | 158.14M |
|
|
|||||
| Total Current Liabilities | 198.93M | 167.65M | 152.89M | 148.70M | 158.14M |
| Long-Term Debt | 391.99M | 391.32M | 390.71M | 390.11M | 389.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.17M | 43.38M | 44.20M | 45.08M | 46.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.30M | 8.65M | 8.49M | 7.10M | 13.48M |
| Total Liabilities | 638.39M | 611.00M | 596.28M | 590.99M | 607.73M |
|
|
|||||
| Common Stock & APIC | 2.98B | 2.96B | 2.94B | 2.93B | 2.91B |
| Retained Earnings | -2.77B | -2.79B | -2.76B | -2.74B | -2.75B |
| Treasury Stock & Other | 22.76M | 30.74M | 12.74M | 5.17M | 25.04M |
| Total Common Equity | 230.42M | 204.30M | 193.56M | 194.05M | 178.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 230.42M | 204.30M | 193.56M | 194.05M | 178.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 230.42M | 204.30M | 193.56M | 194.05M | 178.83M |
|
|
|||||